SFRP5 and type 2 diabetes mellitus: In the subgroup with type 2 diabetes, neither glycaemic control (assessed by HbA1c), duration since the diagnosis of type 2 diabetes nor the type of glucose-lowering medication showed any association with SFRP5 levels (all P > 0.05, Additional file 1: Table S3).